Marshall Wace »

Cognition Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-12-31 $37k 28k 1.35

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Vanguard S&p 500 Etp (VOO)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Eli Lilly & Co Common Stock (LLY)
Alphabet Inc-a Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Adv Micro Device Equity Option Call Option (AMD)
Meta Platforms-a Common Stock (META)
Walmart Common Stock (WMT)
Tesla Common Stock (TSLA)
Alphabet Inc-c Common Stock (GOOG)
Circle Internet Common Stock (CRCL)

View all positions for Marshall Wace

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Davenport & Co
BlackRock
Chescapmanager
Renaissance Technologies
Geode Capital Management
Jane Street
Millennium Management
Hilton Capital Management
Dauntless Investment Group
State Street Corporation
Voss Capital
Sigma Planning
American Financial Group

View all funds holding Cognition Therapeutics